Skip to main content
. 2017 Mar 30;8:162. doi: 10.3389/fphar.2017.00162

FIGURE 1.

FIGURE 1

Endogenous and semisynthetic bile acids as FXR and GPBAR1 agonists. (A) CDCA and TLCA, the endogenous activators of FXR and GPBAR1, respectively. (B) 6-ECDCA, a semisynthetic dual agonist.